Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)
Clinical trial NCT04870164 · TERMINATED
Trial details
- NCT number
- NCT04870164
- Sponsor
- Molecular Partners AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2022-01-06
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.